A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)

Clinical trial NCT06667908 · RECRUITING

Trial details

NCT number: NCT06667908
Sponsor: Johnson & Johnson Enterprise Innovation Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2024-12-06
Primary completion: 2028-12-31
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.